长效注射抗精神病药物对中国精神分裂症患者治疗依从性和医疗保健利用的影响:一项镜像研究

IF 4 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Therapeutic Advances in Psychopharmacology Pub Date : 2025-08-21 eCollection Date: 2025-01-01 DOI:10.1177/20451253251360400
Lei Zhang, Tao Wu, Jingwen Li, Chengxiang Du, Rui Chi, Kun Jiang, Hong Qiu, Yea-Jen Hsu, Wentian Dong, Huaning Wang, Tianmei Si
{"title":"长效注射抗精神病药物对中国精神分裂症患者治疗依从性和医疗保健利用的影响:一项镜像研究","authors":"Lei Zhang, Tao Wu, Jingwen Li, Chengxiang Du, Rui Chi, Kun Jiang, Hong Qiu, Yea-Jen Hsu, Wentian Dong, Huaning Wang, Tianmei Si","doi":"10.1177/20451253251360400","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Long-acting injectable (LAI) antipsychotics can improve treatment adherence in patients with schizophrenia. Despite their benefits, LAIs are underused in China compared to other countries. Little real-world evidence describes the impact of switching from oral to LAI antipsychotics on adherence and healthcare utilization in clinical practice in China, which could help address this gap.</p><p><strong>Objectives: </strong>To understand utilization of LAI and to assess the impact of switching from oral to LAI antipsychotics on adherence and healthcare utilization.</p><p><strong>Design: </strong>This is a retrospective, 1-year mirror-image study using electronic health records (2012-2019) from a psychiatric specialized hospital and the psychiatry department in a general hospital in China. The observation period was 1 year before and after LAI initiation in patients already receiving oral antipsychotics.</p><p><strong>Methods: </strong>Adult patients (aged 18-65) who initiated LAIs after receiving oral antipsychotics, with schizophrenia diagnosis at least 12 months before LAI initiation were included. The date of LAI initiation was designated as the index date. Adherence to antipsychotics was assessed by the proportion of days covered. Schizophrenia-related healthcare utilization comprised the percentage of patients who had admissions, the duration of inpatient stays, the number of inpatient visits, and outpatient visits. Wilcoxon signed-rank test and McNemar's test were used for before-after comparison.</p><p><strong>Results: </strong>Overall, 98 and 59 eligible patients were included in two hospitals, respectively. Treatment adherence (proportion of days covered) after switching increased significantly from 46% to 61% (<i>p</i> < 0.01) and 32% to 58% (<i>p</i> < 0.01), respectively. The frequency of hospital admissions (and cumulative admission days) reduced from 10.2% to 4.1% (6 days to 2 days, <i>p</i> = 0.11), and 55.9% to 10.2% (11 days to 2 days, <i>p</i> < 0.01), respectively. Outpatient visits increased from 5 to 6 visits (<i>p</i> = 0.10), and 7 to 9 visits (<i>p</i> < 0.01), respectively.</p><p><strong>Conclusion: </strong>Consistent benefits of LAIs in enhancing treatment adherence and optimizing healthcare utilization were observed in two representative hospitals having different clinical settings and patient characteristics.</p>","PeriodicalId":23127,"journal":{"name":"Therapeutic Advances in Psychopharmacology","volume":"15 ","pages":"20451253251360400"},"PeriodicalIF":4.0000,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12374043/pdf/","citationCount":"0","resultStr":"{\"title\":\"Effect of long-acting injectable antipsychotics on treatment adherence and healthcare utilization in Chinese patients with schizophrenia: a mirror-image study.\",\"authors\":\"Lei Zhang, Tao Wu, Jingwen Li, Chengxiang Du, Rui Chi, Kun Jiang, Hong Qiu, Yea-Jen Hsu, Wentian Dong, Huaning Wang, Tianmei Si\",\"doi\":\"10.1177/20451253251360400\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Long-acting injectable (LAI) antipsychotics can improve treatment adherence in patients with schizophrenia. Despite their benefits, LAIs are underused in China compared to other countries. Little real-world evidence describes the impact of switching from oral to LAI antipsychotics on adherence and healthcare utilization in clinical practice in China, which could help address this gap.</p><p><strong>Objectives: </strong>To understand utilization of LAI and to assess the impact of switching from oral to LAI antipsychotics on adherence and healthcare utilization.</p><p><strong>Design: </strong>This is a retrospective, 1-year mirror-image study using electronic health records (2012-2019) from a psychiatric specialized hospital and the psychiatry department in a general hospital in China. The observation period was 1 year before and after LAI initiation in patients already receiving oral antipsychotics.</p><p><strong>Methods: </strong>Adult patients (aged 18-65) who initiated LAIs after receiving oral antipsychotics, with schizophrenia diagnosis at least 12 months before LAI initiation were included. The date of LAI initiation was designated as the index date. Adherence to antipsychotics was assessed by the proportion of days covered. Schizophrenia-related healthcare utilization comprised the percentage of patients who had admissions, the duration of inpatient stays, the number of inpatient visits, and outpatient visits. Wilcoxon signed-rank test and McNemar's test were used for before-after comparison.</p><p><strong>Results: </strong>Overall, 98 and 59 eligible patients were included in two hospitals, respectively. Treatment adherence (proportion of days covered) after switching increased significantly from 46% to 61% (<i>p</i> < 0.01) and 32% to 58% (<i>p</i> < 0.01), respectively. The frequency of hospital admissions (and cumulative admission days) reduced from 10.2% to 4.1% (6 days to 2 days, <i>p</i> = 0.11), and 55.9% to 10.2% (11 days to 2 days, <i>p</i> < 0.01), respectively. Outpatient visits increased from 5 to 6 visits (<i>p</i> = 0.10), and 7 to 9 visits (<i>p</i> < 0.01), respectively.</p><p><strong>Conclusion: </strong>Consistent benefits of LAIs in enhancing treatment adherence and optimizing healthcare utilization were observed in two representative hospitals having different clinical settings and patient characteristics.</p>\",\"PeriodicalId\":23127,\"journal\":{\"name\":\"Therapeutic Advances in Psychopharmacology\",\"volume\":\"15 \",\"pages\":\"20451253251360400\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2025-08-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12374043/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutic Advances in Psychopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/20451253251360400\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/20451253251360400","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景:长效注射抗精神病药物可以提高精神分裂症患者的治疗依从性。尽管有这些好处,但与其他国家相比,lai在中国的利用不足。很少有实际证据描述从口服抗精神病药物转向LAI抗精神病药物对中国临床实践中依从性和医疗保健利用的影响,这可能有助于解决这一差距。目的:了解LAI的使用情况,并评估从口服抗精神病药物转向LAI抗精神病药物对依从性和医疗保健利用的影响。设计:这是一项为期1年的回顾性镜像研究,使用来自中国一家精神科专科医院和一家综合医院精神科的电子健康记录(2012-2019)。观察期为已接受口服抗精神病药物患者LAI起始前后1年。方法:纳入在服用口服抗精神病药物后开始LAI的成年患者(18-65岁),并在LAI开始前至少12个月诊断为精神分裂症。将LAI起始日期作为索引日期。通过所覆盖天数的比例来评估抗精神病药物的依从性。精神分裂症相关的医疗保健利用包括住院患者的百分比、住院时间、住院次数和门诊次数。前后比较采用Wilcoxon符号秩检验和McNemar检验。结果:两家医院共纳入98例和59例符合条件的患者。转换后的治疗依从性(覆盖天数的比例)显著增加,从46%增加到61% (p p = 0.11),从55.9%增加到10.2%(11天到2天,p p = 0.10),以及7到9次就诊(p结论:在两家具有不同临床环境和患者特征的代表性医院中,观察到LAIs在提高治疗依从性和优化医疗保健利用方面的一致益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Effect of long-acting injectable antipsychotics on treatment adherence and healthcare utilization in Chinese patients with schizophrenia: a mirror-image study.

Effect of long-acting injectable antipsychotics on treatment adherence and healthcare utilization in Chinese patients with schizophrenia: a mirror-image study.

Effect of long-acting injectable antipsychotics on treatment adherence and healthcare utilization in Chinese patients with schizophrenia: a mirror-image study.

Effect of long-acting injectable antipsychotics on treatment adherence and healthcare utilization in Chinese patients with schizophrenia: a mirror-image study.

Background: Long-acting injectable (LAI) antipsychotics can improve treatment adherence in patients with schizophrenia. Despite their benefits, LAIs are underused in China compared to other countries. Little real-world evidence describes the impact of switching from oral to LAI antipsychotics on adherence and healthcare utilization in clinical practice in China, which could help address this gap.

Objectives: To understand utilization of LAI and to assess the impact of switching from oral to LAI antipsychotics on adherence and healthcare utilization.

Design: This is a retrospective, 1-year mirror-image study using electronic health records (2012-2019) from a psychiatric specialized hospital and the psychiatry department in a general hospital in China. The observation period was 1 year before and after LAI initiation in patients already receiving oral antipsychotics.

Methods: Adult patients (aged 18-65) who initiated LAIs after receiving oral antipsychotics, with schizophrenia diagnosis at least 12 months before LAI initiation were included. The date of LAI initiation was designated as the index date. Adherence to antipsychotics was assessed by the proportion of days covered. Schizophrenia-related healthcare utilization comprised the percentage of patients who had admissions, the duration of inpatient stays, the number of inpatient visits, and outpatient visits. Wilcoxon signed-rank test and McNemar's test were used for before-after comparison.

Results: Overall, 98 and 59 eligible patients were included in two hospitals, respectively. Treatment adherence (proportion of days covered) after switching increased significantly from 46% to 61% (p < 0.01) and 32% to 58% (p < 0.01), respectively. The frequency of hospital admissions (and cumulative admission days) reduced from 10.2% to 4.1% (6 days to 2 days, p = 0.11), and 55.9% to 10.2% (11 days to 2 days, p < 0.01), respectively. Outpatient visits increased from 5 to 6 visits (p = 0.10), and 7 to 9 visits (p < 0.01), respectively.

Conclusion: Consistent benefits of LAIs in enhancing treatment adherence and optimizing healthcare utilization were observed in two representative hospitals having different clinical settings and patient characteristics.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
7.90
自引率
2.40%
发文量
35
审稿时长
10 weeks
期刊介绍: Therapeutic Advances in Psychopharmacology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of psychopharmacology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in psychopharmacology, providing a forum in print and online for publishing the highest quality articles in this area.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信